{"success":true,"data":[{"event_id":"d2611f77-8e14-4814-87d6-9b86fd823e6c","bill_number":null,"short_title":null,"title":"FDA Concludes Existing Regulatory Frameworks Are Not Appropriate for CBD; Calls on Congress to Act","sponsor":null,"cosponsors":[],"jurisdiction":"US","chamber":null,"status":"other","action_date":"2023-01-01T00:00:00.000Z","source_url":"https://www.fda.gov/news-events/public-health-focus/fda-regulation-cannabis-and-cannabis-derived-products-including-cannabidiol-cbd","first_seen_at":"2026-04-24T06:30:49.134Z","source_id":"fda_hemp_cbd","urgency":"CRITICAL","impact_summary":"FDA formally concluded that existing food and dietary supplement frameworks under the FD&C Act are not appropriate for CBD and punted the issue to Congress, signaling no forthcoming rulemaking to legitimize CBD in ingestibles under current authority. This affects every hemp-derived CBD ingestible brand, leaving them in regulatory limbo and exposed to FDA enforcement discretion indefinitely. HempData customers selling CBD foods, beverages, or supplements should document compliance posture now and prepare for a congressional — not agency — solution, which ultimately set the stage for HR 5371 dynamics.","affects_hr5371":true,"affects_s4315":false,"classified_at":"2026-04-24T06:31:10.262Z"},{"event_id":"ca1aa403-95a6-49fe-9b2c-689b86b71480","bill_number":null,"short_title":null,"title":"FDA Warning Letter to Koi CBD, LLC — Adulterated Human Foods (Delta-8 THC Gummies)","sponsor":null,"cosponsors":[],"jurisdiction":"US","chamber":null,"status":"warning_issued","action_date":"2023-07-18T00:00:00.000Z","source_url":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters?search_api_fulltext=CBD+hemp&sort_bef_combine=field_issue_datetime_DESC","first_seen_at":"2026-04-24T06:29:20.900Z","source_id":"fda_warning_letters","urgency":"CRITICAL","impact_summary":"FDA issued a warning letter to Koi CBD declaring delta-8 THC gummies adulterated human food under the FD&C Act, signaling active federal enforcement against hemp-derived delta-8 in ingestible products. This directly affects any HempData customer manufacturing, distributing, or retailing delta-8 edibles. Operators should immediately review product formulations, marketing claims, and distribution channels for delta-8 ingestibles and consult counsel on exposure.","affects_hr5371":false,"affects_s4315":false,"classified_at":"2026-04-24T06:31:58.045Z"},{"event_id":"6f335f49-8829-4427-b43c-f5145242f435","bill_number":null,"short_title":null,"title":"FDA Warning Letter to Discover Health, LLC dba Discover CBD and Strain Snobs — Unapproved New Drugs/Adulterated/Misbranded (Human and Animal CBD Products)","sponsor":null,"cosponsors":[],"jurisdiction":"US","chamber":null,"status":"warning_issued","action_date":"2023-11-16T00:00:00.000Z","source_url":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters?search_api_fulltext=CBD+hemp&sort_bef_combine=field_issue_datetime_DESC","first_seen_at":"2026-04-24T06:29:20.797Z","source_id":"fda_warning_letters","urgency":"CRITICAL","impact_summary":"FDA issued a warning letter to Discover Health, LLC (Discover CBD / Strain Snobs), the U.S. distributor of the Active CBD Oil brand, citing unapproved new drug, adulterated, and misbranded violations across human supplements, pet products, and finished pharmaceuticals. The action reinforces FDA's continued enforcement posture that disease/therapeutic claims on CBD products convert them into unapproved drugs, regardless of hemp-derived status. HempData customers marketing CBD for humans or pets should immediately audit website copy, labels, and social claims for any structure/function or disease language and remove it.","affects_hr5371":false,"affects_s4315":false,"classified_at":"2026-04-24T06:32:10.766Z"},{"event_id":"032e4ff2-55e0-4c76-a378-4a85ff0d02ae","bill_number":null,"short_title":null,"title":"FDA Warning Letter to GCHNC LLC dba Hemp XR / Gate City Hemp / Allaziya Enterprises — Adulterated Delta-8 THC and CBD Products","sponsor":null,"cosponsors":[],"jurisdiction":"US","chamber":null,"status":"warning_issued","action_date":"2023-09-28T00:00:00.000Z","source_url":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters?search_api_fulltext=CBD+hemp&sort_bef_combine=field_issue_datetime_DESC","first_seen_at":"2026-04-24T06:29:20.695Z","source_id":"fda_warning_letters","urgency":"CRITICAL","impact_summary":"FDA issued a warning letter to Hemp XR / GCHNC LLC for selling adulterated delta-8 THC gummies, candy, and CBD/D8 honey products under the FD&C Act's premarket approval provisions. This is direct federal enforcement against hemp-derived cannabinoid edibles, signaling continued FDA posture that delta-8 THC food products are unlawful. HempData customers selling D8 edibles, infused candy, or CBD food products should immediately review labeling, marketing claims, and product categorization, and treat this letter as enforcement precedent.","affects_hr5371":false,"affects_s4315":false,"classified_at":"2026-04-24T06:32:18.193Z"},{"event_id":"04f22e40-b4b5-4ac3-bdec-8a84076c17c2","bill_number":null,"short_title":null,"title":"FDA Warning Letter to East Fork Cultivars (East Fork Hemp, LLC) — Unapproved New Drug/Misbranded Finished Pharmaceuticals","sponsor":null,"cosponsors":[],"jurisdiction":"US","chamber":null,"status":"warning_issued","action_date":"2023-12-22T00:00:00.000Z","source_url":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters?search_api_fulltext=CBD+hemp&sort_bef_combine=field_issue_datetime_DESC","first_seen_at":"2026-04-24T06:29:20.596Z","source_id":"fda_warning_letters","urgency":"CRITICAL","impact_summary":"FDA issued a warning letter to East Fork Hemp, LLC citing unapproved new drug and misbranded pharmaceutical violations for CBD products marketed with disease/health claims on its website and social media. This is a direct federal enforcement action against a hemp-derived cannabinoid brand, signaling continued FDA willingness to pursue CBD marketers making therapeutic claims. HempData customers selling CBD should immediately audit website, social media, and affiliate content for disease/structure-function claims and remove any language referencing treatment, cure, or mitigation of disease.","affects_hr5371":false,"affects_s4315":false,"classified_at":"2026-04-24T06:32:24.260Z"},{"event_id":"8baa1ecc-83ed-484a-8ec8-53d0e5215d2d","bill_number":null,"short_title":null,"title":"FDA Warning Letter to Root Bioscience Brands, LLC dba Naternal — Unapproved New Drugs/Misbranded (CBD, CBG, CBN Products)","sponsor":null,"cosponsors":[],"jurisdiction":"US","chamber":null,"status":"warning_issued","action_date":"2024-08-30T00:00:00.000Z","source_url":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters?search_api_fulltext=CBD+hemp&sort_bef_combine=field_issue_datetime_DESC","first_seen_at":"2026-04-24T06:29:20.493Z","source_id":"fda_warning_letters","urgency":"CRITICAL","impact_summary":"FDA's CDER issued a warning letter to Naternal (Root Bioscience Brands) citing CBD, CBG, and CBN products — including a pet hemp extract — as unapproved new drugs and misbranded under the FDCA, based on disease/health claims on the firm's website. This directly affects every hemp-derived cannabinoid brand making structure/function or therapeutic claims, and expands FDA's active enforcement posture to include minor cannabinoids (CBG, CBN) and pet products, not just CBD. HempData customers should immediately audit all product labeling, website copy, social media, and affiliate content for disease claims across their full cannabinoid SKU range.","affects_hr5371":false,"affects_s4315":false,"classified_at":"2026-04-24T06:32:32.856Z"},{"event_id":"b4d0a197-639a-4d3b-95d0-d7ebe13511c7","bill_number":null,"short_title":null,"title":"FDA Warning Letter to Anne's Daye Ltd dba Tampon Innovations — Adulterated Medical Device (CBD-Coated Tampons)","sponsor":null,"cosponsors":[],"jurisdiction":"US","chamber":null,"status":"warning_issued","action_date":"2024-12-17T00:00:00.000Z","source_url":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters?search_api_fulltext=CBD+hemp&sort_bef_combine=field_issue_datetime_DESC","first_seen_at":"2026-04-24T06:29:20.396Z","source_id":"fda_warning_letters","urgency":"CRITICAL","impact_summary":"FDA's device center issued a warning letter to a firm selling CBD-coated tampons and microbiome kits, citing adulteration and missing IDE/PMA authorizations, with the firm's marketing invoking industrial hemp extracts for pain relief. This is a direct federal enforcement action against a hemp-derived cannabinoid product and signals FDA's willingness to use the medical-device pathway — not just drug/food — to police CBD marketing claims. HempData customers marketing any cannabinoid product with therapeutic claims (topicals, intimate-care, wellness devices) should immediately audit labeling and claim substantiation and confirm whether their product meets the device definition under 21 USC 321(h).","affects_hr5371":false,"affects_s4315":false,"classified_at":"2026-04-24T06:32:40.724Z"},{"event_id":"b7f0c288-7838-415e-8638-04a2eb6883e2","bill_number":null,"short_title":null,"title":"FDA Warning Letter to Pico IV Inc. — Unapproved New Drug (Intravenous CBD)","sponsor":null,"cosponsors":[],"jurisdiction":"US","chamber":null,"status":"warning_issued","action_date":"2025-03-06T00:00:00.000Z","source_url":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters?search_api_fulltext=CBD+hemp&sort_bef_combine=field_issue_datetime_DESC","first_seen_at":"2026-04-24T06:29:20.295Z","source_id":"fda_warning_letters","urgency":"CRITICAL","impact_summary":"FDA's Center for Drug Evaluation and Research issued a warning letter to Pico IV Inc. for marketing an intravenous CBD product as an unapproved new drug and misbranded article. This is a direct FDA enforcement action against a hemp-derived cannabinoid product, signaling continued federal scrutiny of novel CBD delivery formats and therapeutic claims. HempData customers marketing CBD products — particularly with any health/wellness claims or novel delivery routes — should immediately audit marketing copy, social media, and product positioning to avoid drug-claim exposure.","affects_hr5371":false,"affects_s4315":false,"classified_at":"2026-04-24T06:32:46.901Z"},{"event_id":"ee703828-eab0-4349-970a-fba315b05c53","bill_number":null,"short_title":null,"title":"FDA Warning Letter to Holista LLC dba HolistaPet — Unapproved New Animal Drug Products","sponsor":null,"cosponsors":[],"jurisdiction":"US","chamber":null,"status":"warning_issued","action_date":"2025-04-07T00:00:00.000Z","source_url":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters?search_api_fulltext=CBD+hemp&sort_bef_combine=field_issue_datetime_DESC","first_seen_at":"2026-04-24T06:29:20.192Z","source_id":"fda_warning_letters","urgency":"CRITICAL","impact_summary":"FDA's Center for Veterinary Medicine issued a warning letter to HolistaPet for marketing CBD-containing animal products (horse pellets, oils, multi-species formulations) as unapproved new animal drugs, based on website and social media drug claims. This is part of a coordinated April 2025 sweep targeting CBD pet/animal product marketers, signaling active FDA enforcement posture in the animal-hemp vertical. HempData customers selling hemp-derived pet or livestock products should immediately audit their marketing copy, website claims, and social media for any therapeutic or disease-treatment language and scrub structure/function claims that could be read as drug claims.","affects_hr5371":false,"affects_s4315":false,"classified_at":"2026-04-24T06:32:54.134Z"},{"event_id":"d8375176-f921-4815-b16a-a0868658f6b1","bill_number":null,"short_title":null,"title":"FDA Warning Letter to House of Alchemy LLC dba CBD Dog Health / Hamet & Love LLC dba MycoDog — Unapproved New Animal Drug Products","sponsor":null,"cosponsors":[],"jurisdiction":"US","chamber":null,"status":"warning_issued","action_date":"2025-04-07T00:00:00.000Z","source_url":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters?search_api_fulltext=CBD+hemp&sort_bef_combine=field_issue_datetime_DESC","first_seen_at":"2026-04-24T06:29:20.091Z","source_id":"fda_warning_letters","urgency":"CRITICAL","impact_summary":"FDA's Center for Veterinary Medicine issued a warning letter to two hemp-derived CBD pet product companies for marketing unapproved new animal drugs based on drug claims in marketing content, including a blog post. This signals continued active federal enforcement against CBD products — particularly in the animal health segment — and puts every hemp/CBD brand making health or therapeutic claims at direct risk. HempData customers selling CBD pet products or making any structure/function or disease claims should immediately audit website copy, blogs, social media, and third-party affiliate content for drug claims.","affects_hr5371":false,"affects_s4315":false,"classified_at":"2026-04-24T06:33:01.576Z"},{"event_id":"35f30767-f8c2-44fc-a77a-6cb79348d2cb","bill_number":null,"short_title":null,"title":"FDA Issues Warning Letters to Companies Illegally Selling CBD and Delta-8 THC Products","sponsor":null,"cosponsors":[],"jurisdiction":"US","chamber":null,"status":"warning_issued","action_date":"2022-05-01T00:00:00.000Z","source_url":"https://www.fda.gov/news-events/public-health-focus/fda-regulation-cannabis-and-cannabis-derived-products-including-cannabidiol-cbd","first_seen_at":"2026-04-24T06:28:39.050Z","source_id":"fda_hemp_cbd","urgency":"CRITICAL","impact_summary":"FDA issued warning letters to multiple companies illegally marketing CBD and delta-8 THC products making unsubstantiated therapeutic claims, citing FD&C Act violations for unapproved drug claims and prohibited addition of CBD to food and dietary supplements. This directly affects any hemp-derived cannabinoid brand making health claims or selling ingestibles in interstate commerce. HempData customers should immediately audit marketing copy, product labels, and website claims for disease/therapeutic language and review delta-8 product positioning.","affects_hr5371":false,"affects_s4315":false,"classified_at":"2026-04-24T06:33:13.286Z"},{"event_id":"4dbb8cb9-56d0-4ff1-b053-d9a9d605c8b9","bill_number":null,"short_title":null,"title":"FDA Warns Four Companies for Illegally Selling CBD Products Intended for Food-Producing Animals","sponsor":null,"cosponsors":[],"jurisdiction":"US","chamber":null,"status":"warning_issued","action_date":"2022-05-01T00:00:00.000Z","source_url":"https://www.fda.gov/news-events/public-health-focus/fda-regulation-cannabis-and-cannabis-derived-products-including-cannabidiol-cbd","first_seen_at":"2026-04-24T06:28:38.951Z","source_id":"fda_hemp_cbd","urgency":"CRITICAL","impact_summary":"FDA's Center for Veterinary Medicine issued warning letters to four companies selling CBD products for food-producing animals, reinforcing FDA's stance that CBD is not an approved feed additive. This directly affects any hemp/CBD brand marketing to livestock, dairy, or poultry channels, and signals continued federal enforcement risk on cannabinoid animal-product claims. HempData customers in pet/livestock categories should immediately audit product labeling, species claims, and marketing language, and segregate companion-animal SKUs from food-animal channels.","affects_hr5371":false,"affects_s4315":false,"classified_at":"2026-04-24T06:33:20.648Z"},{"event_id":"583e6bd3-f5dd-4728-9142-f0169921ab79","bill_number":null,"short_title":null,"title":"FDA Warns Companies for Illegally Selling CBD-Containing Food and Beverage Products","sponsor":null,"cosponsors":[],"jurisdiction":"US","chamber":null,"status":"warning_issued","action_date":"2022-11-01T00:00:00.000Z","source_url":"https://www.fda.gov/news-events/public-health-focus/fda-regulation-cannabis-and-cannabis-derived-products-including-cannabidiol-cbd","first_seen_at":"2026-04-24T06:28:38.852Z","source_id":"fda_hemp_cbd","urgency":"CRITICAL","impact_summary":"FDA issued warning letters to companies selling CBD-infused food and beverage products, reaffirming its position that adding CBD to conventional food or drinks in interstate commerce violates the FD&C Act. This affects any HempData customer producing, distributing, or retailing CBD-containing ingestibles — particularly beverage brands and food manufacturers. Customers should immediately audit product labeling, marketing claims, and distribution channels, and consult counsel on enforcement exposure.","affects_hr5371":false,"affects_s4315":false,"classified_at":"2026-04-24T06:33:26.403Z"},{"event_id":"73b3e12a-ff6f-488b-9c04-2a068649df37","bill_number":null,"short_title":null,"title":"FDA Concludes Existing Regulatory Frameworks Are Not Appropriate for CBD, Calls on Congress for New Pathway","sponsor":null,"cosponsors":[],"jurisdiction":"US","chamber":null,"status":"other","action_date":"2023-01-01T00:00:00.000Z","source_url":"https://www.fda.gov/news-events/public-health-focus/fda-regulation-cannabis-and-cannabis-derived-products-including-cannabidiol-cbd","first_seen_at":"2026-04-24T06:28:38.754Z","source_id":"fda_hemp_cbd","urgency":"CRITICAL","impact_summary":"FDA formally concluded that existing food and dietary supplement frameworks under the FD&C Act are not appropriate for CBD and called on Congress to build a new regulatory pathway, while denying three related citizen petitions. This directly affects every hemp-derived CBD ingestible brand, which now has no viable FDA pathway absent new legislation. HempData customers should expect intensified enforcement risk on CBD food/supplement claims and should track Congressional response closely.","affects_hr5371":false,"affects_s4315":false,"classified_at":"2026-04-24T06:33:39.219Z"},{"event_id":"3afb4278-e84f-452a-a9f4-fc9e00f61cb2","bill_number":null,"short_title":null,"title":"FDA and FTC Warn Six Companies for Illegally Selling Copycat Food Products Containing Delta-8 THC","sponsor":null,"cosponsors":[],"jurisdiction":"US","chamber":null,"status":"warning_issued","action_date":"2023-07-05T00:00:00.000Z","source_url":"https://www.fda.gov/news-events/public-health-focus/fda-regulation-cannabis-and-cannabis-derived-products-including-cannabidiol-cbd","first_seen_at":"2026-04-24T06:28:38.656Z","source_id":"fda_hemp_cbd","urgency":"CRITICAL","impact_summary":"FDA and FTC jointly issued warning letters to six companies illegally selling copycat food products containing delta-8 THC, signaling active federal enforcement against hemp-derived cannabinoid products that mimic mainstream food brands. This affects any hemp operator selling edibles with packaging resembling conventional food/candy products, exposing them to federal enforcement risk. HempData customers should immediately audit product packaging, branding, and marketing claims for copycat risk and confirm no look-alike trade dress is in their catalog.","affects_hr5371":false,"affects_s4315":false,"classified_at":"2026-04-24T06:33:46.025Z"},{"event_id":"cff16ec7-9bb1-40d1-905d-a43d4a0f881c","bill_number":null,"short_title":null,"title":"FDA and FTC Issue Joint Warning Letters Over Copycat Delta-8 THC Food Products","sponsor":null,"cosponsors":[],"jurisdiction":"US","chamber":null,"status":"warning_issued","action_date":"2024-07-16T00:00:00.000Z","source_url":"https://www.fda.gov/news-events/public-health-focus/fda-regulation-cannabis-and-cannabis-derived-products-including-cannabidiol-cbd","first_seen_at":"2026-04-24T06:28:38.551Z","source_id":"fda_hemp_cbd","urgency":"CRITICAL","impact_summary":"FDA and FTC jointly issued warning letters to companies selling copycat food products containing delta-8 THC, continuing coordinated federal enforcement against hemp-derived cannabinoid products designed to resemble mainstream snacks. This directly affects any HempData customer manufacturing, distributing, or retailing delta-8 edibles, particularly those using packaging that mimics name-brand foods. Customers should immediately audit product packaging for trade-dress risk and review FDA warning letter recipients to confirm they are not named or in the supply chain.","affects_hr5371":false,"affects_s4315":false,"classified_at":"2026-04-24T06:33:52.087Z"},{"event_id":"d31d2f02-bcb5-4c11-a1a6-15bcba8d737c","bill_number":null,"short_title":null,"title":"FDA Issues Warning Letters to Five Companies Selling CBD and Delta-8 THC Products","sponsor":null,"cosponsors":[],"jurisdiction":"US","chamber":null,"status":"warning_issued","action_date":null,"source_url":"https://agi.alabama.gov/hemp/","first_seen_at":"2026-04-24T06:28:13.549Z","source_id":"state_al_hemp","urgency":"CRITICAL","impact_summary":"FDA issued warning letters to five companies for illegally selling delta-8 THC and CBD products, signaling continued federal enforcement against hemp-derived cannabinoid marketers. Any HempData customer selling delta-8 or CBD with health claims, food/beverage formats, or youth-appealing packaging is in the direct line of fire. Customers should immediately audit product labels, marketing claims, and SKUs against FDA's stated violation patterns and retain regulatory counsel if exposure is identified.","affects_hr5371":false,"affects_s4315":false,"classified_at":"2026-04-24T06:34:08.454Z"},{"event_id":"ffc04fd4-3627-4ee8-9271-51e225c47964","bill_number":null,"short_title":null,"title":"FDA and FTC Issue Joint Warning Letters to Five Companies Selling Delta-8 THC Copycat Food Products","sponsor":null,"cosponsors":[],"jurisdiction":"US","chamber":null,"status":"warning_issued","action_date":"2024-07-17T00:00:00.000Z","source_url":"https://agr.georgia.gov/hemp-program","first_seen_at":"2026-04-24T06:28:04.466Z","source_id":"state_ga_hemp","urgency":"CRITICAL","impact_summary":"FDA and FTC issued joint warning letters to five companies selling delta-8 THC food products packaged to mimic mainstream snack brands, citing violations of the Federal Food, Drug, and Cosmetic Act. This is direct federal enforcement against hemp-derived cannabinoid products and signals continued agency appetite for joint FDA/FTC action on copycat packaging. HempData customers should immediately audit product packaging, branding, and marketing for any similarity to national food brands and pull risky SKUs.","affects_hr5371":false,"affects_s4315":false,"classified_at":"2026-04-24T06:34:14.657Z"},{"event_id":"1baa7c9d-69bc-4071-8ef6-dcc903f97284","bill_number":null,"short_title":null,"title":"USDA AMS Delays Enforcement of DEA-Registered Laboratory Requirement for Hemp Testing Until December 31, 2026","sponsor":null,"cosponsors":[],"jurisdiction":"US","chamber":null,"status":"other","action_date":null,"source_url":"https://www.ams.usda.gov/rules-regulations/hemp","first_seen_at":"2026-04-24T06:26:20.693Z","source_id":"state_mo_hemp","urgency":"CRITICAL","impact_summary":"USDA AMS has delayed enforcement of the DEA-registered laboratory testing requirement for hemp until December 31, 2026, giving state, tribal, and federally-operating hemp testing labs additional runway before they must obtain DEA registration. This affects every licensed hemp cultivator and the testing labs serving them under USDA-approved plans. HempData customers with cultivation operations or lab partnerships should confirm current lab status and factor the new deadline into 2026 compliance planning.","affects_hr5371":false,"affects_s4315":false,"classified_at":"2026-04-24T06:35:09.151Z"},{"event_id":"2a68cd39-f7e7-478b-a365-9574602568b2","bill_number":null,"short_title":null,"title":"FDA Warning Letter to Discover Health LLC dba Discover CBD and Strain Snobs – Unapproved New Drugs/Adulterated/Misbranded","sponsor":null,"cosponsors":[],"jurisdiction":"US","chamber":null,"status":"warning_issued","action_date":"2023-11-16T00:00:00.000Z","source_url":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters?search_api_fulltext=CBD+hemp&sort_bef_combine=field_issue_datetime_DESC","first_seen_at":"2026-04-24T06:26:01.389Z","source_id":"fda_warning_letters","urgency":"CRITICAL","impact_summary":"FDA's Center for Drug Evaluation and Research issued a warning letter to Discover Health LLC (Discover CBD / Strain Snobs) citing its Active CBD Oil products as unapproved new drugs, adulterated, and misbranded — spanning human drugs, animal drugs, human foods, and animal foods. This is a multi-category enforcement shot across the bow of any hemp/CBD brand making structure-function or therapeutic claims. HempData customers selling CBD ingestibles should immediately audit product labeling, website claims, and social/testimonial content for disease claims and pull anything that mirrors the cited violations.","affects_hr5371":false,"affects_s4315":false,"classified_at":"2026-04-24T06:35:16.080Z"},{"event_id":"8524429a-eca3-4ece-ba20-580624f197bf","bill_number":null,"short_title":null,"title":"FDA Warning Letter to GCHNC LLC dba Hemp XR – Adulterated Delta-8 THC and CBD Products","sponsor":null,"cosponsors":[],"jurisdiction":"US","chamber":null,"status":"warning_issued","action_date":"2023-09-28T00:00:00.000Z","source_url":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters?search_api_fulltext=CBD+hemp&sort_bef_combine=field_issue_datetime_DESC","first_seen_at":"2026-04-24T06:26:01.289Z","source_id":"fda_warning_letters","urgency":"CRITICAL","impact_summary":"FDA issued a warning letter to GCHNC LLC (Hemp XR) declaring its delta-8 THC gummies and CBD/delta-8 honey products adulterated under food safety law. This is a direct federal enforcement action against a hemp-derived cannabinoid brand selling in food/confectionery formats, signaling continued FDA willingness to police the category independent of HR 5371's 2026 effective date. HempData customers selling delta-8 edibles, infused honey, or CBD food products should immediately review formulation, labeling, and marketing claims for adulteration risk.","affects_hr5371":false,"affects_s4315":false,"classified_at":"2026-04-24T06:35:22.410Z"},{"event_id":"ce2d926a-5c83-4e82-ab88-25a4eb3c0e87","bill_number":null,"short_title":null,"title":"FDA Warning Letter to East Fork Cultivars (East Fork Hemp, LLC) – Unapproved New Drug/Misbranded Finished Pharmaceuticals","sponsor":null,"cosponsors":[],"jurisdiction":"US","chamber":null,"status":"warning_issued","action_date":"2023-12-22T00:00:00.000Z","source_url":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters?search_api_fulltext=CBD+hemp&sort_bef_combine=field_issue_datetime_DESC","first_seen_at":"2026-04-24T06:26:01.191Z","source_id":"fda_warning_letters","urgency":"CRITICAL","impact_summary":"FDA's Office of Unapproved Drugs and Labeling Compliance issued a warning letter to East Fork Hemp, LLC for marketing CBD products as unapproved new drugs based on disease/health claims made on its websites and social media. This signals continued FDA enforcement against hemp-derived CBD brands making therapeutic claims, affecting any hemp-derived cannabinoid company with similar marketing posture. HempData customers should immediately audit their websites, social media, and third-party affiliate content for any disease, structure/function, or unapproved therapeutic claims tied to CBD or other cannabinoids.","affects_hr5371":false,"affects_s4315":false,"classified_at":"2026-04-24T06:35:29.661Z"},{"event_id":"2415d318-029c-41f2-a560-f0baaaf9c33e","bill_number":null,"short_title":null,"title":"FDA Warning Letter to Root Bioscience Brands LLC dba Naternal – Unapproved New Drugs/Misbranded","sponsor":null,"cosponsors":[],"jurisdiction":"US","chamber":null,"status":"warning_issued","action_date":"2024-08-30T00:00:00.000Z","source_url":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters?search_api_fulltext=CBD+hemp&sort_bef_combine=field_issue_datetime_DESC","first_seen_at":"2026-04-24T06:26:01.076Z","source_id":"fda_warning_letters","urgency":"CRITICAL","impact_summary":"FDA's CDER issued a warning letter to Naternal (Root Bioscience Brands) for marketing CBD, CBG, and CBN products — including pet products — as unapproved new drugs based on therapeutic website claims. This reaffirms FDA's enforcement posture that any cannabinoid product with disease or structure/function claims requires drug approval regardless of hemp source. HempData customers selling cannabinoid products should immediately audit website copy, product pages, blog content, and affiliate/influencer claims for therapeutic language.","affects_hr5371":false,"affects_s4315":false,"classified_at":"2026-04-24T06:35:35.896Z"},{"event_id":"fcd165bb-0332-4430-8602-bef8ea404e7a","bill_number":null,"short_title":null,"title":"FDA Warning Letter to Anne's Daye Ltd dba Tampon Innovations – Adulterated Device (CBD-Coated Tampons)","sponsor":null,"cosponsors":[],"jurisdiction":"US","chamber":null,"status":"warning_issued","action_date":"2024-12-17T00:00:00.000Z","source_url":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters?search_api_fulltext=CBD+hemp&sort_bef_combine=field_issue_datetime_DESC","first_seen_at":"2026-04-24T06:26:00.980Z","source_id":"fda_warning_letters","urgency":"CRITICAL","impact_summary":"FDA has issued a warning letter to Anne's Daye Ltd dba Tampon Innovations for marketing CBD-coated tampons as unapproved medical devices, citing adulteration under device provisions due to missing IDE/PMA authorization and pain-relief claims tied to industrial hemp extracts. This expands FDA enforcement logic beyond ingestibles into cannabinoid-infused medical devices, creating new exposure for any hemp brand making therapeutic claims or selling hemp-infused wellness/device hybrids. HempData customers should immediately audit product claims and device classification risk, especially for topicals, intimate-care, and pain-relief SKUs.","affects_hr5371":false,"affects_s4315":false,"classified_at":"2026-04-24T06:35:42.530Z"},{"event_id":"1db49e08-e65e-4ee9-ba17-bb6c4f1a2305","bill_number":null,"short_title":null,"title":"FDA Warning Letter to Pico IV Inc. – Unapproved New Drugs/Misbranded (Intravenous CBD)","sponsor":null,"cosponsors":[],"jurisdiction":"US","chamber":null,"status":"warning_issued","action_date":"2025-03-06T00:00:00.000Z","source_url":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters?search_api_fulltext=CBD+hemp&sort_bef_combine=field_issue_datetime_DESC","first_seen_at":"2026-04-24T06:26:00.882Z","source_id":"fda_warning_letters","urgency":"CRITICAL","impact_summary":"FDA CDER issued a warning letter to Pico IV Inc. for marketing an intravenous CBD product as an unapproved new drug. This is a direct federal enforcement action against a hemp-derived cannabinoid product, signaling FDA's continued willingness to act against novel CBD delivery formats and drug-like marketing claims. HempData customers marketing CBD products — especially in non-traditional delivery formats or with health/therapeutic claims — should immediately audit marketing copy, social media, and product positioning to avoid drug-claim triggers.","affects_hr5371":false,"affects_s4315":false,"classified_at":"2026-04-24T06:35:48.431Z"},{"event_id":"50b24e35-92ec-4356-9b2f-1810fe8d42cb","bill_number":null,"short_title":null,"title":"FDA Warning Letter to Holista LLC dba HolistaPet – Unapproved New Animal Drug Products","sponsor":null,"cosponsors":[],"jurisdiction":"US","chamber":null,"status":"warning_issued","action_date":"2025-04-07T00:00:00.000Z","source_url":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters?search_api_fulltext=CBD+hemp&sort_bef_combine=field_issue_datetime_DESC","first_seen_at":"2026-04-24T06:26:00.784Z","source_id":"fda_warning_letters","urgency":"CRITICAL","impact_summary":"FDA's Center for Veterinary Medicine issued a warning letter to HolistaPet for marketing CBD products for horses and livestock as unapproved new animal drugs, citing drug claims found on the company's website and social media. This affects any hemp/CBD brand selling pet or livestock products with health claims, which is a major product category for HempData customers. Brands should immediately audit marketing copy, websites, and social channels for structure/function or disease claims on animal products and pull any language that implies therapeutic effect.","affects_hr5371":false,"affects_s4315":false,"classified_at":"2026-04-24T06:35:54.509Z"},{"event_id":"fc79593e-e2da-423f-a104-c98d3510ec10","bill_number":null,"short_title":null,"title":"FDA Warning Letter to House of Alchemy LLC dba CBD Dog Health and Hamet & Love LLC dba MycoDog – Unapproved New Animal Drug Products","sponsor":null,"cosponsors":[],"jurisdiction":"US","chamber":null,"status":"warning_issued","action_date":"2025-04-07T00:00:00.000Z","source_url":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters?search_api_fulltext=CBD+hemp&sort_bef_combine=field_issue_datetime_DESC","first_seen_at":"2026-04-24T06:26:00.685Z","source_id":"fda_warning_letters","urgency":"CRITICAL","impact_summary":"FDA's Center for Veterinary Medicine issued a warning letter to two companies marketing CBD pet products as unapproved new animal drugs, citing website and social media claims including a recent blog post. This signals continued FDA enforcement against hemp-derived CBD products making health claims, particularly in the animal product space. HempData customers selling CBD pet products should immediately audit marketing content, blog posts, and social media for any disease or therapeutic claims.","affects_hr5371":false,"affects_s4315":false,"classified_at":"2026-04-24T06:35:59.733Z"},{"event_id":"e173e846-1144-46fa-93ce-8ec2fb9d454d","bill_number":null,"short_title":null,"title":"Federal Funding Legislation Signed by President Trump Includes Hemp-Related Provision","sponsor":null,"cosponsors":[],"jurisdiction":"US","chamber":"joint","status":"signed","action_date":"2025-11-12T00:00:00.000Z","source_url":"https://www.tn.gov/agriculture/farms/hemp-industry.html","first_seen_at":"2026-04-24T06:24:54.505Z","source_id":"state_tn_hemp","urgency":"CRITICAL","impact_summary":"This is the signing of the federal funding legislation containing HR 5371's hemp ban provisions, signed into law by President Trump on November 12, 2025 — establishing the federal hemp-derived cannabinoid ban with a one-year implementation runway (effective Nov 12, 2026). Tennessee's Department of Agriculture has issued the first official state acknowledgment, signaling that state hemp programs will continue under existing law pending federal implementing guidance. HempData customers should immediately begin compliance planning for the Nov 12, 2026 deadline and monitor their state agencies for parallel guidance announcements.","affects_hr5371":true,"affects_s4315":false,"classified_at":"2026-04-24T06:36:28.451Z"},{"event_id":"03179eea-3883-446a-bd14-c420182f171c","bill_number":null,"short_title":null,"title":"USDA AMS Delays Enforcement of DEA-Registered Laboratory Testing Requirement for Hemp Until December 31, 2026","sponsor":null,"cosponsors":[],"jurisdiction":"US","chamber":null,"status":"other","action_date":null,"source_url":"https://www.ams.usda.gov/rules-regulations/hemp","first_seen_at":"2026-04-24T06:24:46.739Z","source_id":"usda_ams_hemp","urgency":"CRITICAL","impact_summary":"USDA AMS has delayed enforcement of the DEA-registered laboratory testing requirement for hemp until December 31, 2026, giving non-DEA-registered labs another year of operational runway under state, tribal, and federal hemp production plans. This directly affects every hemp cultivator, processor, and testing lab operating in the pre-harvest compliance chain. HempData customers should update their lab vendor compliance calendars and flag this as a regulatory reprieve that extends testing flexibility through the same window as the HR 5371 effective date.","affects_hr5371":false,"affects_s4315":false,"classified_at":"2026-04-24T06:36:35.035Z"},{"event_id":"74e2b9fe-85f6-4655-8d11-1967ae28b63c","bill_number":null,"short_title":null,"title":"FDA and FTC Issue Joint Warning Letters to Five Companies Selling Copycat Delta-8 THC Food Products","sponsor":null,"cosponsors":[],"jurisdiction":"US","chamber":null,"status":"warning_issued","action_date":"2024-07-17T00:00:00.000Z","source_url":"https://agr.georgia.gov/hemp-program","first_seen_at":"2026-04-24T06:24:33.753Z","source_id":"state_ga_hemp","urgency":"CRITICAL","impact_summary":"FDA and FTC jointly issued warning letters to five companies selling delta-8 THC food products in copycat packaging of national snack brands, citing FDCA violations. This is a continuing federal enforcement campaign directly targeting hemp-derived cannabinoid products, signaling escalating dual-agency scrutiny of marketing practices. HempData customers selling edible or snack-form hemp products should immediately audit packaging, trade dress, and marketing claims to ensure no similarity to mainstream food brands.","affects_hr5371":false,"affects_s4315":false,"classified_at":"2026-04-24T06:36:40.968Z"},{"event_id":"af36cb8d-0b9a-44f9-9d36-95b46addd510","bill_number":null,"short_title":"Act 158","title":"Vermont Cannabis Control Board Assumes Administration of Hemp Testing, Compliance, and Product Manufacturing Oversight","sponsor":null,"cosponsors":[],"jurisdiction":"VT","chamber":null,"status":"other","action_date":null,"source_url":"https://agriculture.vermont.gov/public-health-agricultural-resource-management-division/hemp-program","first_seen_at":"2026-04-24T06:29:28.104Z","source_id":"state_vt_hemp","urgency":"HIGH","impact_summary":"Vermont has moved hemp product manufacturing, lab certification, and contaminant testing oversight from the Agency of Agriculture to the Cannabis Control Board under Act 158. This splits hemp cultivation (still USDA/Ag) from downstream product manufacturing and compliance (now CCB), meaning Vermont hemp manufacturers and brands shipping into VT will need to re-route licensing, testing, and compliance inquiries through CCB.Info@vermont.gov. HempData customers operating in or selling into Vermont should confirm which agency now holds their license/registration and update compliance workflows accordingly.","affects_hr5371":false,"affects_s4315":false,"classified_at":"2026-04-24T06:31:43.740Z"},{"event_id":"ab8794d0-bfd0-45a4-acef-2fce9ce66e9d","bill_number":null,"short_title":null,"title":"Virginia 2023 Acts of Assembly (Chapters 744 and 794): Hemp Product THC Limits and Retail Registration Requirements","sponsor":null,"cosponsors":[],"jurisdiction":"VA","chamber":null,"status":"finalized","action_date":"2024-11-15T00:00:00.000Z","source_url":"https://www.vdacs.virginia.gov/plant-industry-services-hemp.shtml","first_seen_at":"2026-04-24T06:30:13.925Z","source_id":"state_va_hemp","urgency":"MEDIUM","impact_summary":"Virginia's retail registration requirement under 2023 Acts Chapters 744/794 takes effect November 15, 2024, requiring retailers of smokable and edible hemp products to obtain a VDACS Regulated Hemp Product Retail Facility Registration. The underlying substantive rules (0.3% total THC cap, 2mg/package limit unless 25:1 CBD:THC ratio, ban on synthetic THC for human consumption, topical labeling requirements) were enacted in 2023 and are already in force. HempData customers selling into Virginia should confirm VDACS registration status and verify product formulations and labels comply with the total-THC definition including delta-8 and other isomers.","affects_hr5371":false,"affects_s4315":false,"classified_at":"2026-04-24T06:31:23.164Z"},{"event_id":"d7843711-97e0-4990-91b9-7ffbc0088dea","bill_number":null,"short_title":null,"title":"Vermont Agency of Agriculture Withdraws USDA-Approved Hemp Production Plan, Requires Federal Registration for 2023","sponsor":null,"cosponsors":[],"jurisdiction":"VT","chamber":null,"status":"other","action_date":"2022-12-31T00:00:00.000Z","source_url":"https://agriculture.vermont.gov/public-health-agricultural-resource-management-division/hemp-program","first_seen_at":"2026-04-24T06:29:28.005Z","source_id":"state_vt_hemp","urgency":"MEDIUM","impact_summary":"Vermont ended its state-run hemp production program effective December 31, 2022, shifting all grower and processor registration to USDA's federal Domestic Hemp Production Program via the HeMP platform. Vermont cultivators must now register directly with USDA and provide FBI criminal history reports dated within 60 days of application. This is a jurisdictional handoff rather than a substantive framework change, and it is nearly three years old.","affects_hr5371":false,"affects_s4315":false,"classified_at":"2026-04-24T06:31:52.195Z"},{"event_id":"c1ece587-c280-49b7-8017-78526c50576d","bill_number":null,"short_title":null,"title":"Arizona Industrial Hemp Program – 2025 License Renewals and New Applications Open; Updated Hemp Regulations Now in Effect","sponsor":null,"cosponsors":[],"jurisdiction":"AZ","chamber":null,"status":"other","action_date":null,"source_url":"https://agriculture.az.gov/plantsproduce/industrial-hemp-program","first_seen_at":"2026-04-24T06:25:09.982Z","source_id":"state_az_hemp","urgency":"MEDIUM","impact_summary":"Arizona's Department of Agriculture has opened 2025 Industrial Hemp Program license renewals and new applications, with updated hemp regulations now in effect. This primarily affects industrial hemp cultivators in Arizona, who must file planting reports within five business days and register acreage with USDA-FSA to maintain commerce eligibility. HempData customers operating in AZ should review the updated rules and confirm their renewal and reporting compliance.","affects_hr5371":false,"affects_s4315":false,"classified_at":"2026-04-24T06:36:06.200Z"},{"event_id":"b2e5a2f6-0e09-46e3-b0fb-3a5ce6ee5aa8","bill_number":null,"short_title":null,"title":"USDA Approval of Virginia's Plan to Regulate Hemp Production; VDACS Program Effective January 1, 2022","sponsor":null,"cosponsors":[],"jurisdiction":"VA","chamber":null,"status":"finalized","action_date":"2021-11-19T00:00:00.000Z","source_url":"https://www.vdacs.virginia.gov/plant-industry-services-hemp.shtml","first_seen_at":"2026-04-24T06:30:14.021Z","source_id":"state_va_hemp","urgency":"LOW","impact_summary":"USDA approved Virginia's state hemp production plan under the 2018 Farm Bill, with VDACS assuming regulatory authority over industrial hemp cultivation effective January 1, 2022. This is a routine state-plan approval affecting Virginia hemp growers, who must now register with VDACS, obtain an FSA farm number, and comply with pre-harvest THC testing requirements. Virginia hemp cultivators should review VDACS's grower requirements and transition from USDA-administered licensing to the state program.","affects_hr5371":false,"affects_s4315":false,"classified_at":"2026-04-24T06:31:16.271Z"},{"event_id":"da225df8-91fc-40f2-984e-0141a937b7fb","bill_number":null,"short_title":null,"title":"South Carolina 2025 Hemp Farming Permit Application Period Set for January 1 – February 28, 2025","sponsor":null,"cosponsors":[],"jurisdiction":"SC","chamber":null,"status":"other","action_date":"2025-01-01T00:00:00.000Z","source_url":"https://agriculture.sc.gov/hemp/","first_seen_at":"2026-04-24T06:29:59.634Z","source_id":"state_sc_hemp","urgency":"LOW","impact_summary":"South Carolina's Department of Agriculture opened its routine annual Hemp Farming Permit application window (Jan 1 – Feb 28, 2025) under the existing USDA-approved state hemp plan. This is a scheduling notice for cultivators, not a regulatory change. HempData customers with SC growing operations should ensure applications were submitted within the window, but no action is needed for processors, retailers, or out-of-state operators.","affects_hr5371":false,"affects_s4315":false,"classified_at":"2026-04-24T06:31:28.599Z"},{"event_id":"6a5fdd74-bf5c-4580-bc48-a9c962a0c7a3","bill_number":null,"short_title":null,"title":"Texas Department of Agriculture Opens Hemp Producer Licensing","sponsor":null,"cosponsors":[],"jurisdiction":"TX","chamber":null,"status":"other","action_date":"2020-03-16T00:00:00.000Z","source_url":"https://www.texasagriculture.gov/Regulatory-Programs/Hemp","first_seen_at":"2026-04-24T06:29:42.878Z","source_id":"state_tx_hemp","urgency":"LOW","impact_summary":"Texas Department of Agriculture opened its hemp producer licensing and lot crop permit application portal on March 16, 2020, after USDA approved the state's Hemp Plan. This is a routine administrative rollout affecting Texas hemp cultivators, who must complete orientation, secure producer licenses and lot permits, and comply with sampling and manifest requirements. No action needed for HempData customers beyond awareness; this is historical procedural implementation, not a regulatory shift.","affects_hr5371":false,"affects_s4315":false,"classified_at":"2026-04-24T06:31:37.041Z"},{"event_id":"3d8a4949-c3ae-42e9-93a7-6f344a8c4e68","bill_number":null,"short_title":"Cannabis and Cannabis-Derived Compounds: Quality Considerations for Clinical Research Guidance for Industry","title":"FDA Issues Draft Guidance on Quality Considerations for Clinical Research Involving Cannabis and Cannabis-Derived Compounds","sponsor":null,"cosponsors":[],"jurisdiction":"US","chamber":null,"status":"finalized","action_date":"2023-01-01T00:00:00.000Z","source_url":"https://www.fda.gov/news-events/public-health-focus/fda-regulation-cannabis-and-cannabis-derived-products-including-cannabidiol-cbd","first_seen_at":"2026-04-24T06:28:39.148Z","source_id":"fda_hemp_cbd","urgency":"LOW","impact_summary":"FDA finalized guidance on quality considerations for clinical research involving cannabis and cannabis-derived compounds, aimed at researchers pursuing IND applications. It is a research-pathway document for drug developers, not a rule or enforcement action affecting hemp-derived consumer products. HempData customers selling cannabinoid products have no compliance action required.","affects_hr5371":false,"affects_s4315":false,"classified_at":"2026-04-24T06:33:07.022Z"},{"event_id":"6cb1e39b-f7b8-4f98-944c-b85aed12fbb0","bill_number":null,"short_title":null,"title":"Alabama Department of Agriculture and Industries Opens 2024 Industrial Hemp License Applications","sponsor":null,"cosponsors":[],"jurisdiction":"AL","chamber":null,"status":"other","action_date":null,"source_url":"https://agi.alabama.gov/hemp/","first_seen_at":"2026-04-24T06:28:13.648Z","source_id":"state_al_hemp","urgency":"LOW","impact_summary":"The Alabama Department of Agriculture and Industries has opened its routine annual 2024 application window for industrial hemp grower and processor/handler licenses. This is standard program administration under Alabama's existing Industrial Hemp Program and does not change the regulatory framework. Alabama-based growers and processors wishing to participate in the 2024 season should submit applications through ADAI.","affects_hr5371":false,"affects_s4315":false,"classified_at":"2026-04-24T06:33:59.987Z"},{"event_id":"12c5cab2-45b1-49db-8d86-77d24775747c","bill_number":null,"short_title":"Georgia Hemp Farming Act","title":"Georgia Department of Agriculture Hemp Program Overview and 2026 License Year Opening","sponsor":null,"cosponsors":[],"jurisdiction":"GA","chamber":null,"status":"other","action_date":"2025-11-01T00:00:00.000Z","source_url":"https://agr.georgia.gov/hemp-program","first_seen_at":"2026-04-24T06:28:04.260Z","source_id":"state_ga_hemp","urgency":"LOW","impact_summary":"The Georgia Department of Agriculture opened its 2026 hemp license application and renewal window on November 1, 2025 under the existing Georgia Hemp Farming Act framework. This is a routine annual licensing cycle with no substantive regulatory change; growers, processors, manufacturers, and retailers operating in Georgia should complete 2025 planting/harvest/disposal reports by December 1, 2025 before renewing. No action is required of HempData customers beyond normal compliance calendar awareness.","affects_hr5371":false,"affects_s4315":false,"classified_at":"2026-04-24T06:34:20.212Z"},{"event_id":"16ece57a-3c7a-4086-9d69-619a1d361220","bill_number":null,"short_title":"Agriculture Improvement Act of 2018","title":"2018 Farm Bill Signed, Permanently Legalizing Hemp as Agricultural Commodity","sponsor":null,"cosponsors":[],"jurisdiction":"US","chamber":"joint","status":"signed","action_date":"2018-12-20T00:00:00.000Z","source_url":"https://agriculture.delaware.gov/plant-industries/hemp-program/","first_seen_at":"2026-04-24T06:27:49.261Z","source_id":"state_de_hemp","urgency":"LOW","impact_summary":"This is a historical reference to the 2018 Farm Bill, which was signed nearly seven years ago and established the federal legal framework for hemp as an agricultural commodity. While foundational to the entire hemp industry, this is not a new regulatory event and has already been superseded in key respects by HR 5371. HempData customers should treat this as background context, not actionable news.","affects_hr5371":false,"affects_s4315":false,"classified_at":"2026-04-24T06:34:25.664Z"},{"event_id":"63d6434a-7102-4245-b8b2-c0749cdc1edf","bill_number":null,"short_title":"Rules and Regulations for Delaware Domestic Hemp Production Program","title":"USDA Approves Delaware State Hemp Production Plan; Delaware Regulations Take Effect","sponsor":null,"cosponsors":[],"jurisdiction":"DE","chamber":null,"status":"finalized","action_date":"2020-01-27T00:00:00.000Z","source_url":"https://agriculture.delaware.gov/plant-industries/hemp-program/","first_seen_at":"2026-04-24T06:27:49.161Z","source_id":"state_de_hemp","urgency":"LOW","impact_summary":"Delaware's state hemp production plan was approved by USDA in January 2020 and finalized via regulation in March 2021. This is a historical, routine state hemp-cultivation program approval and does not affect hemp-derived cannabinoid product regulation, HR 5371, or S.4315. Delaware licensees should simply ensure continued compliance with Regulation 805 for cultivation activities.","affects_hr5371":false,"affects_s4315":false,"classified_at":"2026-04-24T06:34:31.202Z"},{"event_id":"9c9167a9-ec69-404b-bb3a-981e78f16f25","bill_number":null,"short_title":null,"title":"North Carolina Industrial Hemp Pilot Program Expired; Regulatory Authority Transferred to USDA","sponsor":null,"cosponsors":[],"jurisdiction":"NC","chamber":null,"status":"other","action_date":"2022-06-30T00:00:00.000Z","source_url":"https://www.ncagr.gov/divisions/plant-industry/hemp-nc","first_seen_at":"2026-04-24T06:27:14.727Z","source_id":"state_nc_hemp","urgency":"LOW","impact_summary":"North Carolina's state industrial hemp pilot program expired on June 30, 2022, with regulatory authority over hemp cultivation transferring to the USDA's Domestic Hemp Production Program. NC hemp growers and processors now obtain licenses directly from USDA-AMS rather than NCDA&CS. This is a historical administrative transition affecting cultivation licensing only, not cannabinoid product regulation, and has no bearing on HR 5371 or current hemp-derived product compliance strategy.","affects_hr5371":false,"affects_s4315":false,"classified_at":"2026-04-24T06:34:39.419Z"},{"event_id":"c4cea648-9fe6-44b4-bec4-183b5f17cab2","bill_number":null,"short_title":null,"title":"USDA Approval of VDACS Plan to Regulate Hemp Production in Virginia Under 2018 Farm Bill","sponsor":null,"cosponsors":[],"jurisdiction":"VA","chamber":null,"status":"finalized","action_date":"2021-11-19T00:00:00.000Z","source_url":"https://www.vdacs.virginia.gov/plant-industry-services-hemp.shtml","first_seen_at":"2026-04-24T06:27:07.253Z","source_id":"state_va_hemp","urgency":"LOW","impact_summary":"USDA approved Virginia's state hemp production plan under the 2018 Farm Bill back in November 2021, with the framework taking effect January 1, 2022. This is a routine, historical administrative approval governing industrial hemp cultivation (0.3% total delta-9 THC limit), not finished cannabinoid products. No action is required by HempData customers — this is background regulatory context.","affects_hr5371":false,"affects_s4315":false,"classified_at":"2026-04-24T06:34:47.924Z"},{"event_id":"65c095a9-0b19-44a0-bcd9-519add8c2692","bill_number":null,"short_title":null,"title":"South Carolina Maintains Ban on Hemp and CBD in Commercial Animal Feed","sponsor":null,"cosponsors":[],"jurisdiction":"SC","chamber":null,"status":"other","action_date":null,"source_url":"https://agriculture.sc.gov/hemp/","first_seen_at":"2026-04-24T06:26:49.664Z","source_id":"state_sc_hemp","urgency":"LOW","impact_summary":"The South Carolina Department of Agriculture has reiterated its existing ban on hemp and CBD in commercial animal feed, aligning with ongoing federal FDA restrictions. This affects hemp permittees and animal feed manufacturers in SC, but represents no policy change — only a restatement of current law. Customers operating in SC should continue excluding hemp/CBD from commercial feed formulations.","affects_hr5371":false,"affects_s4315":false,"classified_at":"2026-04-24T06:34:52.771Z"},{"event_id":"de88e84f-464a-4e7d-a45d-7291d5fa1fe5","bill_number":null,"short_title":null,"title":"South Carolina Department of Agriculture Announces 2025 Hemp Farming Permit Application Period (Jan. 1–Feb. 28, 2025)","sponsor":null,"cosponsors":[],"jurisdiction":"SC","chamber":null,"status":"other","action_date":"2025-01-01T00:00:00.000Z","source_url":"https://agriculture.sc.gov/hemp/","first_seen_at":"2026-04-24T06:26:49.563Z","source_id":"state_sc_hemp","urgency":"LOW","impact_summary":"The South Carolina Department of Agriculture opened its routine annual hemp farming permit window (Jan 1–Feb 28, 2025) under its existing USDA-approved state hemp plan. This affects only South Carolina hemp growers, processors, and handlers seeking permits for the 2025 season and does not change any regulatory framework, potency rules, or product categories. HempData customers need only note the standard annual deadline if they operate in SC.","affects_hr5371":false,"affects_s4315":false,"classified_at":"2026-04-24T06:34:57.487Z"},{"event_id":"5aa0b083-5723-4291-890b-ab139569d686","bill_number":"H.R. 2","short_title":"Agriculture Improvement Act","title":"2018 Farm Bill (H.R. 2) Legalizes Commercial Hemp Production Federally","sponsor":null,"cosponsors":[],"jurisdiction":"US","chamber":"joint","status":"signed","action_date":null,"source_url":"https://www.texasagriculture.gov/Regulatory-Programs/Hemp","first_seen_at":"2026-04-24T06:26:32.370Z","source_id":"state_tx_hemp","urgency":"LOW","impact_summary":"This is a historical reference to the 2018 Farm Bill (H.R. 2), which federally legalized commercial hemp production and established the state-plan framework under USDA. It is foundational law already known to every hemp operator and is not a new regulatory event. HempData customers require no action.","affects_hr5371":false,"affects_s4315":false,"classified_at":"2026-04-24T06:35:02.941Z"},{"event_id":"768e2142-2419-4d38-ac7c-6d709d76a7a3","bill_number":null,"short_title":null,"title":"Arizona Industrial Hemp Program – Hemp Microgreens Commercial Production Protocol Approved Effective January 1, 2022","sponsor":null,"cosponsors":[],"jurisdiction":"AZ","chamber":null,"status":"finalized","action_date":"2022-01-01T00:00:00.000Z","source_url":"https://agriculture.az.gov/plantsproduce/industrial-hemp-program","first_seen_at":"2026-04-24T06:25:09.881Z","source_id":"state_az_hemp","urgency":"LOW","impact_summary":"Arizona has approved a USDA-vetted compliance protocol allowing licensed hemp growers to commercially produce hemp microgreens and greens starting January 1, 2022, substituting pre-flowering visual inspection and verified seed for THC sampling at maturity. This affects Arizona-licensed hemp growers pursuing microgreen/greens crops, not downstream cannabinoid product manufacturers or retailers. HempData customers in the cannabinoid product space have no action to take; Arizona microgreen growers should register with USDA-FSA and comply with SP21-02.","affects_hr5371":false,"affects_s4315":false,"classified_at":"2026-04-24T06:36:13.541Z"},{"event_id":"3dd32a6b-03cf-4c63-9fa6-b29f35059e23","bill_number":null,"short_title":null,"title":"Arizona Department of Agriculture Industrial Hemp Program – Enforcement Discretion of DEA-Registered Laboratory Testing Requirement Extended to December 31, 2024","sponsor":null,"cosponsors":[],"jurisdiction":"AZ","chamber":null,"status":"other","action_date":null,"source_url":"https://agriculture.az.gov/plantsproduce/industrial-hemp-program","first_seen_at":"2026-04-24T06:25:09.780Z","source_id":"state_az_hemp","urgency":"LOW","impact_summary":"Arizona's Department of Agriculture is extending an enforcement discretion window (until Dec 31, 2024) for the rule requiring hemp testing at DEA-registered labs, mirroring a parallel USDA delay. This is a procedural accommodation for pre-harvest compliance testing under the industrial hemp production program and does not change Arizona's consumable hemp product rules, potency caps, or retail framework. Licensed hemp growers in AZ can continue using non-DEA-registered labs for compliance testing during the extension; HempData customers in the consumer-products space are effectively unaffected.","affects_hr5371":false,"affects_s4315":false,"classified_at":"2026-04-24T06:36:21.689Z"},{"event_id":"7622981e-45fc-4548-9e49-63eb8ec6bbc4","bill_number":null,"short_title":"Georgia Hemp Farming Act","title":"Georgia Department of Agriculture Hemp Program — 2026 License Year Now Open","sponsor":null,"cosponsors":[],"jurisdiction":"GA","chamber":null,"status":"other","action_date":"2025-11-01T00:00:00.000Z","source_url":"https://agr.georgia.gov/hemp-program","first_seen_at":"2026-04-24T06:24:33.547Z","source_id":"state_ga_hemp","urgency":"LOW","impact_summary":"Georgia opened its 2026 hemp license renewal window on November 1, 2025, with a December 1 deadline for 2025 compliance reporting. This is routine annual administrative activity under the existing Georgia Hemp Farming Act, not a change to the regulatory framework. HempData customers who are licensed Georgia growers/processors should note the renewal deadline but no action beyond normal compliance is required.","affects_hr5371":false,"affects_s4315":false,"classified_at":"2026-04-24T06:36:48.155Z"}],"meta":{"count":50,"days":30,"urgency":null,"api_version":"v1"}}